Special edition of CDA Update addresses nationwide opioid epidemic

The September 2018 issue of the Update, CDA’s monthly news magazine, focuses entirely on the opioid crisis gripping America and on dentistry’s leadership role in this crisis.

“CDA began addressing the opioid abuse issue more than three years ago, but the escalation of the crisis tells us that now is a good time to pull together all our resources and efforts and provide a look at the issue in California and CDA’s leadership on it,” said CDA Editor Kerry K. Carney, DDS.

Articles include “Rethinking pain management in our dental practices,” by Solomon Poyourow, DDS, MD, MPH, and “End first exposure: Dentistry’s biggest opportunity in the opioid crisis” by Dr. Carney. Other articles discuss legislative efforts to curb opioid abuse, alternatives to opioids for managing pain, regulatory compliance with CURES 2.0 – California’s prescription drug monitoring program, instructions for prescribing controlled substances electronically and rules for storing and disposing of controlled substances.

“CDA has been busy, working with regulators, legislators and our members to reduce opioid use in California, and you can be sure we will continue that work,” Dr. Carney said.

Read the September issue of the Update and visit the online archive for past issues. 

Related Items

The next DEA National Prescription Drug Take Back Day is set for Saturday, Oct. 27, and more than 300 locations in California are prepared to help people dispose of unused prescription drugs safely and anonymously. Health care providers can encourage their patients and others to dispose of prescription drugs from 10 a.m. to 2 p.m. Patients should also be made aware that they can also dispose of unused prescription drugs year-round at designated locations.

The Department of Justice announced that California’s Controlled Substance Utilization Review and Evaluation System, also known as CURES 2.0, is ready for statewide use and that mandatory CURES consultation becomes effective Oct. 2, 2018. Beginning on this date, prescribers must check a patient’s prescription history in CURES 2.0 before prescribing a Schedule II-IV substance, with some exceptions.

On the legislative front, in California alone, more than two dozen bills that address opioid prescription and misuse are working their way through the Legislature, including several by Assemblymember Jim Wood, DDS. Meanwhile, CDA continues to provide education and resources on opioid prescribing to members and dentists throughout California. In May at CDA Presents The Art and Science of Dentistry in Anaheim, CDA Public Affairs will host “Clinical and Legal Considerations for Prescribing Controlled Substances.”